4-Methylpyrazole
-
4-Methylpyrazole
structure -
-
CAS No:
7554-65-6
-
Formula:
C4H6N2
-
Chemical Name:
4-Methylpyrazole
-
Synonyms:
1H-Pyrazole,4-methyl-;Pyrazole,4-methyl-;4-Methyl-1H-pyrazole;4-Methylpyrazole;4-MP;Fomepizole;Antizol
- Categories:
-
CAS No:
Description
Fomepizole is a competitive inhibitor of the enzyme alcohol dehydrogenase which plays a key role in the metabolism of ethylene glycol and methanol.
Solid
Fomepizole is a member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4. It has a role as an antidote, a protective agent and an EC 1.1.1.1 (alcohol dehydrogenase) inhibitor. It derives from a hydride of a 1H-pyrazole.|Fomepizole is used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning. Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.|Fomepizole is an Antidote.|Fomepizole is a pyrazole with competitive alcohol dehydrogenase inhibitor activity. Fomepizole prevents the metabolism of ethylene glycol and methanol by alcohol dehydrogenase, thereby inhibiting the formation of their toxic metabolites, glycolate and oxalate (from ethylene glycol), and formic acid (from methanol). Fomepizole is indicated for use as an antidote in ethylene glycol and methanol poisoning. (NCI05)|A pyrazole and competitive inhibitor of ALCOHOL DEHYDROGENASE that is used for the treatment of poisoning by ETHYLENE GLYCOL or METHANOL.
4-Methylpyrazole Basic Attributes
82.1
82.10
231-445-0
83LCM6L2BY
760365
DTXSID3040649
C47538
V - Various
2933199090
Characteristics
28.7
1.4
Solid
1.1±0.1 g/cm3
15.5-18.5 °C
206 °C
96.1±0.0 °C
1.523
soluble
2-8ºC
LD50 (7 days) in mice, rats (mmol/kg): 3.8, 3.8 i.v.; 7.8, 6.5 orally (Magnusson)
Safety Information
III
6.1(b)
2810
3
R22;R36/37/38
S26-S36-S24/25
UQ7350000
Xn:Harmful;
Stable under normal temperatures and pressures.
P261-P305 + P351 + P338
H302-H315-H319-H335
|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P260, P261, P264, P270, P271, P280, P301+P312, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 135 companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis
Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. Ethylene glycol is first metabolized to glycoaldehyde which then undergoes further oxidation to glycolate, glyoxylate, and oxalate. Glycolate and oxalate are primarily responsible for metabolic acidosis and renal damage seen in ethylene glycol toxicity. {01}{03} Methanol is first metabolized to formaldehyde and then undergoes subsequent oxidation via formaldehyde dehydrogenase to become formic acid. It is formic acid that is primarily responsible for the metabolic acidosis and visual disturbances that are associated with methanol poisoning.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)|Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Rapid and complete|In healthy volunteers, only 1-3.5% of the administered dose of Antizol® (7-20 mg/kg oral and IV) was excreted unchanged in the urine, indicating that metabolism is the major route of elimination. In humans, the primary metabolite of Antizol® is 4-carboxypyrazole (approximately 80-85% of administered dose), which is excreted in the urine. The metabolites of Antizol® are excreted renally.|0.6 to 1.02 L/kg
Primarily hepatic. the primary metabolite is 4-carboxypyrazole (approximately 80 to 85% of an administered dose). Minor metabolites include 4-hydroxymethylpyrazole and the N -glucuronide conjugates of 4-carboxypyrazole and 4-hydroxymethylpyrazole.
The plasma half-life of Antizol varies with dose, even in patients with normal renal function, and has not been calculated.
Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.
4 Methylpyrazole
4-Methylpyrazole Use and Manufacturing
Into a 5 liter flask equipped with a mechanical stirrer were added 1750 ml of sterile USP water to which 266.7 g (2.05 moles) of hydrazine hydrosulfate were added gradually over one hour with stirring. To the above mixture was added dropwise 481 g (2.053 moles) of 3 and the reaction mixture was warmed to 80°C. Heating and stirring were maintained for 3 hours, the flask was cooled to 40°C, and the volatile components were distilled off under a reduced pressure of about 125 mm. The resulting mixture was EPO Into a 5 liter flask equipped with a mechanical stirrer were added 1750 ml of sterile USP water to which 266.7 g (2.05 moles) of hydrazine hydrosulfate were added gradually over one hour with stirring. To the above mixture was added dropwise 481 g (2.053 moles) of 3 and the reaction mixture was warmed to 80 C. Heating and stirring were maintained for 3 hours, the flask was cooled to 40 C., and the volatile components were distilled off under a reduced pressure of about 125 mm. The resulting mixture was cooled to 10 C. first with water and then with glycol; 20 ml of water were added to the flask, and cooling was continued to a temperature of 3 C. Thereafter 50percent sodium hydroxide solution was added with cooling so as to maintain the temperature below 30 C. The pH of the reaction mixture should be between 4 and 6. A solution of sodium bicarbonate containing 4.9 g of sodium bicarbonate to 55 ml of water was added to the flask. Additional sodium bicarbonate solution was added until the pH reached 7.0. The flask temperature was allowed to rise to 27 C. with continued stirring. The contents of the flask were extracted with ethyl acetate and the aqueous layer was separated. The organic layer was dried over magnesium sulfate, filtered, and the extract was distilled under vacuum. The light fraction was removed at a pot temperature of 55-60 C. at 125 mm pressure. The vacuum was improved to 5 mm for the remainder of the distillation; pot temperatures were permitted to rise to 100-110 C. to produce 134.8 g (84percent based on 3) of 4-methylpyrazole, bp 77-80 C. at 5 mm, as a clear, colorless to yellow liquid. Gas chromatographic analysis showed less than 0.1percent pyrazole and less than 10 ppm hydrazine.a, taking 3-amino-2-methyl acrolein 100g, toluene 500ml, Tetrabutylammonium chloride 16.3g was added to the reactor, take formamide 52.9g, Added to 79.4g of water made of 40percent aqueous solution of formamide, added to the reactor, the reaction at room temperature for 1h, Heating to 80 reaction 3h. After the reaction was completed, the temperature of the reaction solution was cooled to room temperature, The organic phase was taken, the organic phase was washed three times with 500ml of water, the organic phase was dried over anhydrous magnesium sulfate for 2h, Filtration, the filtrate was evaporated to give crude 4-methylpyrazole 91g;b, 4-methylpyrazole crude distillationThe crude 4-methylpyrazole obtained in step a was added into a vacuum distillation reactor with a rectification column, For the 0.09 ~ 0.097Mpa conditions collected 110 ~ 116 ° C distillate, to give a clear colorless liquid, which is 4 - methyl pyrazole refined products82g
Useful as an antidote in methanol and ethylene glycol poisoning. Antidote in methanol or ethylene glycol poisoning;Alcohol dehydrogenase inhibitor antidote to ethylene glycol or methanol poisoning
Human drugs -> Rare disease (orphan)|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:82.10
XLogP3:1.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Exact Mass:82.053098200
Monoisotopic Mass:82.053098200
Topological Polar Surface Area:28.7
Heavy Atom Count:6
Complexity:44.8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Price Analysis
Recommended Suppliers of 4-Methylpyrazole
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed Additive -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 7554-65-6Grade: Industrial GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of amino acid derivatives,pharmaceutical intermediates,oligonucleotide reagent
Learn More Other Chemicals
-
4-Methylpyrazole hydrochloride
56010-88-9
-
2-[[2-[[1-(2-aminoethyl)piperidin-4-yl]amino]-4-methylbenzimidazol-1-yl]methyl]-6-methylpyridin-3-ol
317846-22-3
-
N-ethyl-2-methoxy-N-(2-methoxyethyl)ethanamine
109907-05-3
-
4-[[(2R)-2-Hydroxy-3-methyl-3-buten-1-yl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one Formula
33783-80-1
-
dodeca-5,7-dienal Formula
75539-65-0
-
(9-hydroxy-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl) 2-methylbut-2-enoate Formula
150135-35-6
-
4,5-Dihydro-2-methylthiophene Structure
4610-02-0
-
2-fluoro-1H-imidazole Structure
57212-34-7
-
What is 1,3-thiazol-5-ylmethyl N-[(2S,4S,5S)-4-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
202816-62-4
-
What is (3S)-morpholine-3-carboxylic acid
106825-79-0